DiaMedica Therapeutics (DMAC) EPS (Basic) (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported EPS (Basic) of -$0.19 for Q1 2026, down 5.56% on a YoY basis from -$0.2 in Q1 2025, and down 11.76% quarter-over-quarter from -$0.17 in Q4 2025.
DiaMedica Therapeutics (DMAC) EPS (Basic) (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.19 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 5.56% year-over-year to -$0.19; the trailing twelve-month figure through Mar 2026 stood at -$0.71 (down 10.94% YoY), and the FY2025 full-year result was -$0.7, down 16.67% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.19, down from -$0.17 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.12 in Q3 2022, with the low at -$0.2 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.15 across 5 years, with a median of -$0.15 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 33.33% — and 2023, when it plunged 53.85%.
- DiaMedica Therapeutics' EPS (Basic) stood at -$0.14 in 2022, then increased by 0.0% to -$0.14 in 2023, then decreased by 28.57% to -$0.18 in 2024, then gained by 5.56% to -$0.17 in 2025, then retreated by 11.76% to -$0.19 in 2026.
- The last three EPS (Basic) figures came in at -$0.19 (Q1 2026), -$0.17 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 0.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.06 |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.19 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.20 |
| Dec 31, 2022 | -0.14 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.13 |
| Mar 31, 2022 | -0.13 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | -0.17 |